MDXH MDxHealth SA
Company Analysis
Latest News
🔴 MDxHealth is trading 5.6% down in after-hours trading; no company-specific catalyst identified
MDxHealth is trading at $0.18, down 5.60% after hours on October 26, 2026; no company-specific announcement explaining the decline was found. - The broad...
🟢 MDxHealth is trading 7.36% up today amid broader market gains
MDxHealth is trading 7.36% higher at $0.20, amid a broader market advance; no direct link to the move has been reported. - Broader markets rose on October 26...
🔴 MDxHealth is trading 10.15% down amid AI-spending concerns and rising oil prices
MDxHealth is trading at $0.19, down 10.15%, amid broader market pressure. - Supplied price context shows consecutive gains before the October 22 decline; no...
🔴 MDxHealth is trading 9.22% down today amid broader market declines
MDxHealth is trading at $0.20, down 9.22%, with no confirmed fresh company catalyst identified. - The latest company release, dated October 15, reported...
🔴 MDxHealth is trading 6.84% down in after-hours trading with no verified company-specific catalyst
MDxHealth is trading 6.84% down at $0.20 after-hours, with no verified company-specific catalyst in the available information. - No new company announcement...
🟢 MDxHealth is trading 10% up today as healthcare stocks gain
MDxHealth is trading at $0.21, up 10.29%, in a move that appears consistent with healthcare-sector strength. - No new company-specific catalyst was identified...
🟢 MDxHealth is trading 5.6% up today — no confirmed company-specific catalyst
MDxHealth is trading at $0.21, up 5.56%, with no new company-specific announcement identified to explain the October 21 move. - Healthcare is up 2.12% in the...
🟢 MDxHealth is trading 6% up — no company-specific catalyst identified
MDxHealth is trading at $0.19, up +6.11%, with no new company-specific announcement identified to explain the October 20 move. - The October 15 preliminary Q3...
🟢 MDxHealth is trading 7% up in after-hours trading with no clear catalyst identified
MDxHealth is trading at $0.20, up 6.99%, with no clear catalyst identified. - The search found no new announcement explaining the October 19 after-hours...
🔴 MDxHealth is trading 11.2% down after suspending full-year 2026 revenue guidance
MDxHealth is trading at $0.18, down 11.23%, after suspending full-year 2026 revenue guidance. - On October 15, the company reported preliminary Q3 revenue of...
🔴 MDxHealth is trading 9.44% down after suspending 2026 revenue guidance
MDxHealth is trading 9.44% down now at $0.19 after suspending 2026 revenue guidance following preliminary third-quarter revenue of approximately $22.7 million,...
🔴 MDxHealth is trading 9.92% down after suspending 2026 revenue guidance
MDxHealth is trading 9.92% lower at $0.19 after suspending 2026 revenue guidance following a preliminary Q3 revenue miss. - Preliminary Q3 revenue was...
🔴 MDxHealth is trading 5.1% down in pre-market after suspending full-year 2026 revenue guidance
MDxHealth is trading 5.1% lower at $0.20 pre-market after suspending 2026 revenue guidance. - Q3 revenue was about $22.7 million, flat year over year;...
🔴 MDxHealth is trading 6.34% down in after-hours trading after suspending 2026 guidance on Q3 revenue shortfall
MDxHealth is trading at $0.19, down 6.34% in after-hours trading after suspending 2026 guidance following a Q3 revenue shortfall. - Preliminary Q3 revenue was...
🔴 MDxHealth is trading 41% down today after suspending 2026 guidance on Q3 revenue miss
MDxHealth is trading 40.77% down at $0.36 after suspending full-year 2026 revenue guidance of $110–115 million; preliminary Q3 revenue was approximately $22.7...
🔴 MDxHealth is trading 14.3% down in pre-market after suspending full-year 2026 revenue guidance
MDxHealth is trading at $0.52, down 14.26% in pre-market after suspending its $110–115 million full-year 2026 revenue guidance. - Announced October 15,...
🔴 MDxHealth is trading 11.4% down in after-hours trading after suspending full-year 2026 revenue guidance
MDxHealth is trading at $0.53, down 11.40% in after-hours trading after suspending its $110–115 million 2026 revenue guidance. - Preliminary Q3 revenue was...
MDxHealth Suspends Revenue Guidance After Sales Team Exodus — Can a Sub-Dollar Stock Rebuild Investor Trust?
Shares of MDxHealth plunged 8.9% to $0.55 after the Belgian-American diagnostics company pulled its full-year revenue forecast, citing a sales-force shakeup...
🔴 MDxHealth is trading 8.88% down in after-hours trading after suspending 2026 revenue guidance
MDxHealth is trading at $0.55 (-8.88%) in after-hours trading after suspending its 2026 revenue guidance. - Preliminary third-quarter revenue was...
🔴 MDxHealth is trading 5% down amid inflation-driven rate concerns
MDxHealth is trading 5.1% down at $0.60 on October 15, 2026, with the decline coinciding with inflation-driven rate concerns weighing on technology and other...